Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Eledon to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at WTC
July 17, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at WTC 2025
June 25, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
May 14, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
March 20, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
March 04, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
February 07, 2025 10:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Announces Tegoprubart Use as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
January 29, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Eledon Pharmaceuticals to Participate in Guggenheim SMID Cap Biotech Conference
January 13, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
November 12, 2024 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Next Page keyboard_arrow_right